GlassScriptPhysician profile
Michael L Volk
NPI 1679628317
$65,459.55
in general payments reported to CMS, 2019-2025
18 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,838 · 2020: $16K · 2021: $29K · 2022: $13K · 2023: $252 · 2024: $55.11 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54,637.33 | 2019-2023 | Xifaxan |
| Boston Scientific Corporation | $4,696.50 | 2019-2022 | |
| Fujifilm Wako Diagnostics U.S.A. Corporation | $2,100.53 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $2,100.00 | 2021 | |
| Gilead Sciences, INC. | $749.97 | 2019-2025 | |
| Abbvie INC. | $247.58 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $177.71 | 2025 | Iqirvo |
| Intercept Pharmaceuticals, INC. | $144.01 | 2019-2021 | |
| Shionogi INC | $141.22 | 2019 | |
| Pentax of America, INC. | $132.75 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $98.20 | 2019 | |
| Mallinckrodt Hospital Products INC. | $68.30 | 2020-2023 | Terlivaz |
| Madrigal Pharmaceuticals | $55.11 | 2024 | Resmetirom |
| Ethicon US, LLC | $24.89 | 2020 | |
| Genzyme Corporation | $23.21 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $22.60 | 2021 | |
| Covidien LP | $22.37 | 2019 | |
| Merck Sharp & Dohme LLC | $17.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Volk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.